| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0925059A1 Protein-lipid vesicles and autogenous vaccine comprising the same |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | EP0924985A1 Method for inhibiting the expression of fas |
| 06/30/1999 | EP0749429B1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments |
| 06/30/1999 | CN1221452A Hybrid interferon compositions and method of use |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221424A 肽衍生物 Peptide derivatives |
| 06/30/1999 | CN1221403A Compounds with anti-inflammatory and immunosuppressive activities |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1221341A Use of benzonaphthalene derivatives to make medicaments for treating disease of central nervous system |
| 06/30/1999 | CN1043883C Vitamin D analogues, medicinal composition containing the same and medical use thereof |
| 06/29/1999 | US5917014 Methods of treating inflammation and compositions therefor |
| 06/29/1999 | US5916922 For inhibiting human non-pancreatic secretory phospholipase a2 |
| 06/29/1999 | US5916906 Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin B6 |
| 06/29/1999 | US5916885 Treatment of psoriasis, dermatitis |
| 06/29/1999 | US5916878 Dipeptide of either gamma-glutamyl-l-tryptophan or beta-aspartyl-l-tryptophan; administering to the patients to reduce the risks infections from microorganism |
| 06/29/1999 | US5916590 Soft gelatin pharmaceutical dosage form |
| 06/29/1999 | US5916571 Cleaving a streptococcus pneumoniae serotype 8-polysaccharide into oligosaccharides to preserve immunogenic epitopes, separating above oligosaccharides based on size, selecting oligosaccharide which conatins antigen, mixing with antigen |
| 06/29/1999 | US5916560 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
| 06/29/1999 | US5916559 For organ transplants |
| 06/29/1999 | US5916558 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | CA2130275C Use of substituted adenine derivatives for treating multiple sclerosis |
| 06/29/1999 | CA2016584C Anthracycline conjugates having a novel linker and methods for their production |
| 06/29/1999 | CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin |
| 06/24/1999 | WO1999031252A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031225A2 Human phosphatases |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031126A1 Cyclopeptide derivatives with integrin inhibitor properties |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999031105A1 3-substituted adenines via2-thioxanthines |
| 06/24/1999 | WO1999031104A1 Preparation of 3-substituted adenines and imidazo pyridines |
| 06/24/1999 | WO1999031103A1 Preparation of 3-substituted adenines |
| 06/24/1999 | WO1999031102A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | WO1999031087A1 Cyclic imide-substituted pyridylalkane, alkene and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031073A1 Novel pyrimidine-5-carboxamide derivatives |
| 06/24/1999 | WO1999031066A1 Pyridones as src family sh2 domain inhibitors |
| 06/24/1999 | WO1999031064A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031063A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
| 06/24/1999 | WO1999031060A2 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 06/24/1999 | WO1999031052A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | WO1999030741A2 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases |
| 06/24/1999 | WO1999030737A1 Use of microparticles combined with submicron oil-in-water emulsions |
| 06/24/1999 | WO1999030736A2 Methods to treat undesirable immune responses |
| 06/24/1999 | WO1999030733A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | WO1999030725A1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 06/24/1999 | WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 06/24/1999 | WO1999030710A1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 06/24/1999 | WO1999030703A1 Use of formoterol in medicament for inflammation/allergy in upper airways |
| 06/24/1999 | WO1999030699A1 Modulators of cysteine protease |
| 06/24/1999 | WO1999019480A3 Human receptor proteins; related reagents and methods |
| 06/24/1999 | CA2315537A1 Methods to treat undesirable immune responses |
| 06/24/1999 | CA2315527A1 Human phosphatases |
| 06/24/1999 | CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | CA2314884A1 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | CA2314379A1 Human dendriac and brainiac-3 |
| 06/24/1999 | CA2314355A1 Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors |
| 06/24/1999 | CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | CA2313649A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | CA2313448A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | CA2313212A1 Modulators of cysteine protease |
| 06/24/1999 | CA2313005A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | CA2313004A1 3-substituted adenines via2-thioxanthines |
| 06/23/1999 | EP0924297A1 Sialoadhesin family member-2 (saf-2) |
| 06/23/1999 | EP0923940A1 Peptide-base immunotherapeutic agent for allergic diseases |
| 06/23/1999 | EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/23/1999 | EP0923644A1 G-coupled receptor showing selective affinity for atp |
| 06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
| 06/23/1999 | EP0923604A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923581A1 4-substituted beta-carbolines as immunomodulators |
| 06/23/1999 | EP0923570A1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 06/23/1999 | EP0923373A1 Il-8 receptor antagonists |
| 06/23/1999 | CN1220699A Antibodies against interferon alpha/beta receptor |
| 06/23/1999 | CN1220670A Inhibitor and stimulator of stem cell proliferationa and use thereof |
| 06/23/1999 | CN1220656A Novel trienoic retinoid compounds and method |
| 06/23/1999 | CN1220263A Novel hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof |
| 06/22/1999 | US5914406 Azepanes and their ring homologues having protein kinase inhibiting activity |
| 06/22/1999 | US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells |
| 06/22/1999 | US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue |
| 06/22/1999 | US5914260 Fish pancreatic disease virus |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin |
| 06/22/1999 | US5914110 Contacting biological fluid sample of the patient suffering from excess immunoglobulins e production in a human with monoclonal antibody or fusion protein and detecting the presence or absence of complex of antibody and interleukin-4 |
| 06/22/1999 | US5914106 Interleukin-6 receptor agonists |
| 06/22/1999 | CA2169066C Phenoxyphenyl cyclopentenyl hydroxyureas |
| 06/22/1999 | CA2147893C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis .beta. virus activity |
| 06/22/1999 | CA1340608C Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/20/1999 | CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease |
| 06/20/1999 | CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases |
| 06/17/1999 | WO1999029883A2 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease |
| 06/17/1999 | WO1999029873A1 Cyclic gmp phosphodiesterase |
| 06/17/1999 | WO1999029863A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | WO1999029849A1 G-protein coupled receptors associated with immune response |